Literature DB >> 27920038

TGF-β Family Signaling in the Control of Cell Proliferation and Survival.

Yun Zhang1, Peter B Alexander1, Xiao-Fan Wang1.   

Abstract

The transforming growth factor β (TGF-β) family controls many fundamental aspects of cellular behavior. With advances in the molecular details of the TGF-β signaling cascade and its cross talk with other signaling pathways, we now have a more coherent understanding of the cytostatic program induced by TGF-β. However, the molecular mechanisms are still largely elusive for other cellular processes that are regulated by TGF-β and determine a cell's proliferation and survival, apoptosis, dormancy, autophagy, and senescence. The difficulty in defining TGF-β's roles partly stems from the context-dependent nature of TGF-β signaling. Here, we review our current understanding and recent progress on the biological effects of TGF-β at the cellular level, with the hope of providing a framework for understanding how cells respond to TGF-β signals in specific contexts, and why disruption of such mechanisms may result in different human diseases including cancer.
Copyright © 2017 Cold Spring Harbor Laboratory Press; all rights reserved.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 27920038      PMCID: PMC5378054          DOI: 10.1101/cshperspect.a022145

Source DB:  PubMed          Journal:  Cold Spring Harb Perspect Biol        ISSN: 1943-0264            Impact factor:   10.005


  146 in total

Review 1.  TGFβ biology in cancer progression and immunotherapy.

Authors:  Rik Derynck; Shannon J Turley; Rosemary J Akhurst
Journal:  Nat Rev Clin Oncol       Date:  2020-07-24       Impact factor: 66.675

Review 2.  The complexity of TGFβ/activin signaling in regeneration.

Authors:  René Fernando Abarca-Buis; Edna Ayerim Mandujano-Tinoco; Alejandro Cabrera-Wrooman; Edgar Krötzsch
Journal:  J Cell Commun Signal       Date:  2021-01-22       Impact factor: 5.782

3.  Cross-Linked Polyphenol-Based Drug Nano-Self-Assemblies Engineered to Blockade Prostate Cancer Senescence.

Authors:  Prashanth K B Nagesh; Pallabita Chowdhury; Elham Hatami; Sonam Kumari; Vivek Kumar Kashyap; Manish K Tripathi; Santosh Wagh; Bernd Meibohm; Subhash C Chauhan; Meena Jaggi; Murali M Yallapu
Journal:  ACS Appl Mater Interfaces       Date:  2019-10-08       Impact factor: 9.229

Review 4.  Specificity, versatility, and control of TGF-β family signaling.

Authors:  Rik Derynck; Erine H Budi
Journal:  Sci Signal       Date:  2019-02-26       Impact factor: 8.192

5.  CXCL1 Derived from Mammary Fibroblasts Promotes Progression of Mammary Lesions to Invasive Carcinoma through CXCR2 Dependent Mechanisms.

Authors:  Shira Bernard; Megan Myers; Wei Bin Fang; Brandon Zinda; Curtis Smart; Diana Lambert; An Zou; Fang Fan; Nikki Cheng
Journal:  J Mammary Gland Biol Neoplasia       Date:  2018-08-09       Impact factor: 2.673

6.  Dual roles of TGF-β signaling in the regulation of dental epithelial cell proliferation.

Authors:  Hao Zhang; Yunyan Zhan; Yue Zhang; Guohua Yuan; Guobin Yang
Journal:  J Mol Histol       Date:  2020-11-18       Impact factor: 2.611

Review 7.  The Spectrinome: The Interactome of a Scaffold Protein Creating Nuclear and Cytoplasmic Connectivity and Function.

Authors:  Steven R Goodman; Daniel Johnson; Steven L Youngentob; David Kakhniashvili
Journal:  Exp Biol Med (Maywood)       Date:  2019-09-04

8.  SMAD4 mutations and cross-talk between TGF-β/IFNγ signaling accelerate rates of DNA damage and cellular senescence, resulting in a segmental progeroid syndrome-the Myhre syndrome.

Authors:  Renuka Kandhaya-Pillai; Deyin Hou; Jiaming Zhang; Xiaomeng Yang; Goli Compoginis; Takayasu Mori; Tamara Tchkonia; George M Martin; Fuki M Hisama; James L Kirkland; Junko Oshima
Journal:  Geroscience       Date:  2021-01-05       Impact factor: 7.713

9.  Prolonged survival of transplanted stem cells after ischaemic injury via the slow release of pro-survival peptides from a collagen matrix.

Authors:  Andrew S Lee; Mohammed Inayathullah; Maarten A Lijkwan; Xin Zhao; Wenchao Sun; Sujin Park; Wan Xing Hong; Mansi B Parekh; Andrey V Malkovskiy; Edward Lau; Xulei Qin; Venkata Raveendra Pothineni; Verónica Sanchez-Freire; Wendy Y Zhang; Nigel G Kooreman; Antje D Ebert; Charles K F Chan; Patricia K Nguyen; Jayakumar Rajadas; Joseph C Wu
Journal:  Nat Biomed Eng       Date:  2018-02-06       Impact factor: 25.671

10.  MiR-3606-3p inhibits systemic sclerosis through targeting TGF-β type II receptor.

Authors:  Xiangguang Shi; Qingmei Liu; Na Li; Wenzhen Tu; Ruoyu Luo; Xueqian Mei; Yanyun Ma; Weihong Xu; Haiyan Chu; Shuai Jiang; Zhimin Du; Han Zhao; Liang Zhao; Li Jin; Wenyu Wu; Jiucun Wang
Journal:  Cell Cycle       Date:  2018-09-17       Impact factor: 4.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.